EVH
Evolent Health Inc
3.60$
+2.6%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +47.7% | -94.5% | +336.3% | -12.8% | -240.5% | – | -764.5% | – | +208.6% | -102.0% | – | – | |
| – | -8.6% | -0.3% | +5.0% | -4.1% | +2.7% | -13.3% | -12.5% | +2.0% | -290.7% | – | +91.8% | – | |
| – | +3.7% | +77.2% | -32.6% | +13.9% | -142.4% | – | +4.5% | +26.8% | -116.3% | – | +142.7% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +82.8% | -160.0% | – | – | – | – | – | – | – | -131.6% | – | – | |
| – | -10.9% | -11.6% | +32.9% | -11.5% | -2.2% | +39.7% | +2.0% | +2.2% | -13.4% | -17.5% | +106.9% | – | |
| – | -98.5% | +60.8% | +39.1% | +45.7% | +1.0% | -34.3% | +362.3% | -85.5% | – | -107.8% | +104.6% | – | |
| – | +1.3% | -1.6% | -0.2% | +1.3% | -6.4% | -4.8% | +1.0% | -58.3% | -100.0% | – | – | – | |
| – | -100.6% | +1,418.4% | -97.5% | +90.1% | -55.2% | +1,381.6% | -99.4% | +142,742.9% | +27.8% | -96.4% | – | – | |
| – | – | – | – | – | – | +168.2% | -100.0% | – | -4,907.2% | -100.0% | – | – | |
| – | +125.7% | – | -794.7% | -91.3% | – | +11.3% | -108.3% | +368.4% | +122.5% | -95.7% | +276.7% | – | |
| – | -106.8% | – | -1,040.5% | – | – | +96.5% | -188.0% | – | – | -131.8% | – | – | |
| – | +55.1% | -100.5% | – | -13.5% | -361.5% | – | – | – | +499.1% | -118.0% | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.